Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome

Endocrine

Volumn 41, Issue 3, 2012, Pages 442-449

  Majumdar, I ^a   Mastrandrea, L D ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Insulin resistance; Metabolic syndrome; Obesity; Sphingolipids

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CERAMIDE; FATTY ACID; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SPHINGOLIPID BLOOD LEVEL;

EID: 84862648634     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9589-4     Document Type: Article

References (32)

1. C. Ogden, M. Carroll, NCHS health e-stat: prevalence of obesity among children and adolescents: United States, trends 1963-1965 through 2007-2008. http://www.cdc.gov/nchs/data/hestat/obesity-child-07-08/obesity-child-07-08.htm (2010). Accessed 12 December 2011
2. R. Sinha, G. Fisch, B. Teague, W.V. Tamborlane, B. Banyas, K. Allen, M. Savoye, V. Rieger, S. Taksali, G. Barbetta, R.S. Sherwin, S. Caprio, Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N. Engl. J. Med. 346(11), 802-810 (2002) (Pubitemid 34984653)
3. Y. Aggoun, Obesity, metabolic syndrome, and cardiovascular disease. Pediatr. Res. 61(6), 653-659 (2007) (Pubitemid 46804930)
4. P.W. Wilson, R.B. D'Agostino, H. Parise, L. Sullivan, J.B. Meigs, Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112(20), 3066-3072 (2005) (Pubitemid 43113437)
5. J.C. Pickup, Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27(3), 813-823 (2004) (Pubitemid 38280558)
6. C. Herder, S. Schneitler, W. Rathmann, B. Haastert, H. Schneitler, H. Winkler, R. Bredahl, E. Hahnloser, S. Martin, Low-grade inflammation, obesity, and insulin resistance in adolescents. J. Clin. Endocrinol. Metab. 92(12), 4569-4574 (2007) (Pubitemid 350223428)
7. I. Aeberli, L. Molinari, G. Spinas, R. Lehmann, D. l'Allemand, M.B. Zimmermann, Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. Am. J. Clin. Nutr. 84(4), 748-755 (2006) (Pubitemid 44715656)
8. Y.S. Moon, D.H. Kim, D.K. Song, Serum tumor necrosis factoralpha levels and components of the metabolic syndrome in obese adolescents. Metabolism 53(7), 863-867 (2004)
9. P. Peraldi, G.S. Hotamisligil, W.A. Buurman, M.F. White, B.M. Spiegelman, Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 271(22), 13018-13022 (1996)
10. Y.A. Hannun, The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269(5), 3125-3128 (1994) (Pubitemid 24237615)
11. S. Spiegel, O. Cuvillier, L.C. Edsall, T. Kohama, R. Menzeleev, Z. Olah, A. Olivera, G. Pirianov, D.M. Thomas, Z. Tu, J.R. Van Brocklyn, F. Wang, Sphingosine-1-phosphate in cell growth and cell death. Ann. N. Y. Acad. Sci. 845, 11-18 (1998) (Pubitemid 28365296)
12. J.M. Haus, S.R. Kashyap, T. Kasumov, R. Zhang, K.R. Kelly, R.A. DeFronzo, J.P. Kirwan, Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58(2), 337-343 (2009)
13. H. Huang, T. Kasumov, P. Gatmaitan, H.M. Heneghan, S.R. Kashyap, P.R. Schauer, S.A. Brethauer, J.P. Kirwan, Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity 19, 2235-2240 (2011)
14. L. Wang, X.P. Xing, A. Holmes, C. Wadham, J.R. Gamble, M.A. Vadas, P. Xia, Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ. Res. 97(9), 891-899 (2005) (Pubitemid 41552674)
15. D. English, Z. Welch, A.T. Kovala, K. Harvey, O.V. Volpert, D.N. Brindley, J.G. Garcia, Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 14(14), 2255-2265 (2000)
16. N. Murata, K. Sato, J. Kon, H. Tomura, M. Yanagita, A. Kuwabara, M. Ui, F. Okajima, Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352(Pt 3), 809-815 (2000) (Pubitemid 32015038)
17. P. Hanel, P. Andreani, M.H. Graler, Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J. 21(4), 1202-1209 (2007) (Pubitemid 46495709)
18. O. Cuvillier, G. Pirianov, B. Kleuser, P.G. Vanek, O.A. Coso, S. Gutkind, S. Spiegel, Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381(6585), 800-803 (1996) (Pubitemid 26243122)
19. F. Samad, K.D. Hester, G. Yang, Y.A. Hannun, J. Bielawski, Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55(9), 2579-2587 (2006) (Pubitemid 44871159)
20. R.J. Kuczmarski, C.L. Ogden, S.S. Guo, L.M. Grummer-Strawn, K.M. Flegal, Z. Mei, R. Wei, L.R. Curtin, A.F. Roche, C.L. Johnson, 2000 CDC growth charts for the United States: methods and development. Vital Health Stat. 11(246), 1-190 (2002)
21. H. Yokoyama, M. Emoto, S. Fujiwara, K. Motoyama, T. Morioka, M. Komatsu, H. Tahara, T. Shoji, Y. Okuno, Y. Nishizawa, Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 26(8), 2426-2432 (2003) (Pubitemid 36993338)
22. B. Rosner, R.J. Prineas, J.M. Loggie, S.R. Daniels, Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States. J. Pediatr. 123(6), 871-886 (1993) (Pubitemid 23353249)
23. C. Li, E.S. Ford, A.H. Mokdad, S. Cook, Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics 118(5), e1390-e1398 (2006) (Pubitemid 46393642)
24. S. Cook, P. Auinger, C. Li, E.S. Ford, Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J. Pediatr. 152(2), 165-170 (2008)
25. J.M. Lee, M.J. Okumura, M.M. Davis, W.H. Herman, J.G. Gurney, Prevalence and determinants of insulin resistance among US adolescents. Diabetes Care 29(11), 2427-2432 (2006) (Pubitemid 44912247)
26. A. Gupta, S. Ten, H. Anhalt, Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children. J. Pediatr. Endocrinol. Metab. 18(1), 75-82 (2005) (Pubitemid 40227875)
27. R. Weiss, J. Dziura, T.S. Burgert, W.V. Tamborlane, S.E. Taksali, C.W. Yeckel, K. Allen, M. Lopes, M. Savoye, J. Morrison, R.S. Sherwin, S. Caprio, Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350(23), 2362-2374 (2004) (Pubitemid 38702847)
28. M. Nikolova-Karakashian, E.T. Morgan, C. Alexander, D.C. Liotta, A.H. Merrill Jr., Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. J. Biol. Chem. 272(30), 18718-18724 (1997) (Pubitemid 27318216)
29. L.D. Mastrandrea, S.M. Sessanna, S.G. Laychock, Sphingosine kinase activity and sphingosine-1 phosphate production in rat pancreatic islets and INS-1 cells: response to cytokines. Diabetes 54(5), 1429-1436 (2005) (Pubitemid 40586674)
30. A.U. Blachnio-Zabielska, M. Pulka, M. Baranowski, A. Nikolajuk, P. Zabielski, M. Górska, J. Górski, Ceramide metabolism is affected by obesity and diabetes in human adipose tissue. J. Cell Physiol. 227, 550-557 (2012)
31. S.M. Hammad, J.S. Pierce, F. Soodavar, K.J. Smith, M.M. Al Gadban, B. Rembiesa, R.L. Klein, Y.A. Hannun, J. Bielawski, A. Bielawska, Blood sphingolipidomics in healthy humans: impact of sample collection methodology. J. Lipid Res. 51(10), 3074-3087 (2010)
32. G. Delogu, G. Famularo, F. Amati, L. Signore, A. Antonucci, V. Trinchieri, L. Di Marzio, M.G. Cifone, Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome. Crit. Care Med. 27(11), 2413-2417 (1999)